Use of neurokinin receptor antagonists to treat androgen-dependent diseases

Use of neurokinin receptor antagonists to treat androgen-dependent diseases

Use of an antagonist selected from the group consisting of: (a) antagonists of neurokinin-1 (NK1), neurokinin-2 (NK2) and neurokinin-3 (NK3) receptors, (b) antagonists of NK1 and NK2 receptors, (c) antagonists of NK2 and NK3 receptors, (d) antagonists of NK1 and NK3 receptors, (e) antagonists of NK1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BERARDI MARK R, PACHTER JONATHAN A, CARTWRIGHT MARK E, MIRRO ELMER J, SINHA DINESHWAR, LEACH MICHAEL W, REICHARD GREGORY A
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BERARDI MARK R
PACHTER JONATHAN A
CARTWRIGHT MARK E
MIRRO ELMER J
SINHA DINESHWAR
LEACH MICHAEL W
REICHARD GREGORY A
description Use of an antagonist selected from the group consisting of: (a) antagonists of neurokinin-1 (NK1), neurokinin-2 (NK2) and neurokinin-3 (NK3) receptors, (b) antagonists of NK1 and NK2 receptors, (c) antagonists of NK2 and NK3 receptors, (d) antagonists of NK1 and NK3 receptors, (e) antagonists of NK1 receptors, and (f) antagonists of NK2 to treat symptoms and disorders associated with a production and/or secretion of androgen. One aspect of the invention relates to the use of antagonists to suppress production/secretion of androgens in mammals suffering from an androgen-dependent disease, such as benign prostatic hyperplasia and prostatic carcinoma.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US6569872B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US6569872B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US6569872B13</originalsourceid><addsrcrecordid>eNqNyjEKwkAQRuFtLES9w1wgRRSjaZWIYKmpw5D9ExZlZtkZ76-FB7B68PGW4dYbSCcSvIs-kyShghHZtRCL86ySzI1cyQvYvxiLzpAqIkMixCkmAxtsHRYTvwybX1eBLt3jfK2QdYBlHiHwob83-6Y9HranevfH8gFDdzXx</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use of neurokinin receptor antagonists to treat androgen-dependent diseases</title><source>esp@cenet</source><creator>BERARDI MARK R ; PACHTER JONATHAN A ; CARTWRIGHT MARK E ; MIRRO ELMER J ; SINHA DINESHWAR ; LEACH MICHAEL W ; REICHARD GREGORY A</creator><creatorcontrib>BERARDI MARK R ; PACHTER JONATHAN A ; CARTWRIGHT MARK E ; MIRRO ELMER J ; SINHA DINESHWAR ; LEACH MICHAEL W ; REICHARD GREGORY A</creatorcontrib><description>Use of an antagonist selected from the group consisting of: (a) antagonists of neurokinin-1 (NK1), neurokinin-2 (NK2) and neurokinin-3 (NK3) receptors, (b) antagonists of NK1 and NK2 receptors, (c) antagonists of NK2 and NK3 receptors, (d) antagonists of NK1 and NK3 receptors, (e) antagonists of NK1 receptors, and (f) antagonists of NK2 to treat symptoms and disorders associated with a production and/or secretion of androgen. One aspect of the invention relates to the use of antagonists to suppress production/secretion of androgens in mammals suffering from an androgen-dependent disease, such as benign prostatic hyperplasia and prostatic carcinoma.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030527&amp;DB=EPODOC&amp;CC=US&amp;NR=6569872B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25555,76308</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030527&amp;DB=EPODOC&amp;CC=US&amp;NR=6569872B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERARDI MARK R</creatorcontrib><creatorcontrib>PACHTER JONATHAN A</creatorcontrib><creatorcontrib>CARTWRIGHT MARK E</creatorcontrib><creatorcontrib>MIRRO ELMER J</creatorcontrib><creatorcontrib>SINHA DINESHWAR</creatorcontrib><creatorcontrib>LEACH MICHAEL W</creatorcontrib><creatorcontrib>REICHARD GREGORY A</creatorcontrib><title>Use of neurokinin receptor antagonists to treat androgen-dependent diseases</title><description>Use of an antagonist selected from the group consisting of: (a) antagonists of neurokinin-1 (NK1), neurokinin-2 (NK2) and neurokinin-3 (NK3) receptors, (b) antagonists of NK1 and NK2 receptors, (c) antagonists of NK2 and NK3 receptors, (d) antagonists of NK1 and NK3 receptors, (e) antagonists of NK1 receptors, and (f) antagonists of NK2 to treat symptoms and disorders associated with a production and/or secretion of androgen. One aspect of the invention relates to the use of antagonists to suppress production/secretion of androgens in mammals suffering from an androgen-dependent disease, such as benign prostatic hyperplasia and prostatic carcinoma.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwkAQRuFtLES9w1wgRRSjaZWIYKmpw5D9ExZlZtkZ76-FB7B68PGW4dYbSCcSvIs-kyShghHZtRCL86ySzI1cyQvYvxiLzpAqIkMixCkmAxtsHRYTvwybX1eBLt3jfK2QdYBlHiHwob83-6Y9HranevfH8gFDdzXx</recordid><startdate>20030527</startdate><enddate>20030527</enddate><creator>BERARDI MARK R</creator><creator>PACHTER JONATHAN A</creator><creator>CARTWRIGHT MARK E</creator><creator>MIRRO ELMER J</creator><creator>SINHA DINESHWAR</creator><creator>LEACH MICHAEL W</creator><creator>REICHARD GREGORY A</creator><scope>EVB</scope></search><sort><creationdate>20030527</creationdate><title>Use of neurokinin receptor antagonists to treat androgen-dependent diseases</title><author>BERARDI MARK R ; PACHTER JONATHAN A ; CARTWRIGHT MARK E ; MIRRO ELMER J ; SINHA DINESHWAR ; LEACH MICHAEL W ; REICHARD GREGORY A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US6569872B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BERARDI MARK R</creatorcontrib><creatorcontrib>PACHTER JONATHAN A</creatorcontrib><creatorcontrib>CARTWRIGHT MARK E</creatorcontrib><creatorcontrib>MIRRO ELMER J</creatorcontrib><creatorcontrib>SINHA DINESHWAR</creatorcontrib><creatorcontrib>LEACH MICHAEL W</creatorcontrib><creatorcontrib>REICHARD GREGORY A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERARDI MARK R</au><au>PACHTER JONATHAN A</au><au>CARTWRIGHT MARK E</au><au>MIRRO ELMER J</au><au>SINHA DINESHWAR</au><au>LEACH MICHAEL W</au><au>REICHARD GREGORY A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use of neurokinin receptor antagonists to treat androgen-dependent diseases</title><date>2003-05-27</date><risdate>2003</risdate><abstract>Use of an antagonist selected from the group consisting of: (a) antagonists of neurokinin-1 (NK1), neurokinin-2 (NK2) and neurokinin-3 (NK3) receptors, (b) antagonists of NK1 and NK2 receptors, (c) antagonists of NK2 and NK3 receptors, (d) antagonists of NK1 and NK3 receptors, (e) antagonists of NK1 receptors, and (f) antagonists of NK2 to treat symptoms and disorders associated with a production and/or secretion of androgen. One aspect of the invention relates to the use of antagonists to suppress production/secretion of androgens in mammals suffering from an androgen-dependent disease, such as benign prostatic hyperplasia and prostatic carcinoma.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US6569872B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Use of neurokinin receptor antagonists to treat androgen-dependent diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T02%3A10%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERARDI%20MARK%20R&rft.date=2003-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS6569872B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true